Abstract:We read with interest the study by Boursier et al. titled “A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis” recently published in the Journal.[1] Boursier J. de Ledinghen V. Leroy V. Anty R. Francque S. Salmon D. et al. A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis. J Hepatol. 2017; 66: 1158-1165 Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar Using liver biopsy as reference in a cross-sectional study, the authors developed a stepwise algorithm for the detection of advanced liver fibrosis. This algorithm comprised of a first-line test called easy liver fibrosis test (eLIFT), followed by a second-line test of FibroMeter plus vibration controlled transient elastography (FMVCTE). When tested in a longitudinal cohort of 1,275 patients, the eLIFT-FMVCTE algorithm showed promising prognostic performance. This algorithm provides a potential method to extend the detection of advanced liver fibrosis to all chronic liver disease patients and to reduce unnecessary referrals of patients without significant fibrosis to hepatologists. A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosisJournal of HepatologyVol. 66Issue 6PreviewChronic liver diseases (CLD) are very common: worldwide, an estimated 160 million people have chronic hepatitis C [1], 240 million have chronic hepatitis B [2], and 25% of the general population has non-alcoholic fatty liver disease (NAFLD) [3]. CLD can lead to a progressive accumulation of fibrosis in the liver which progressively evolves to cirrhosis and its life-threatening complications such as hepatocellular carcinoma (HCC), liver failure, variceal bleeding, or renal insufficiency. In 2012, driven by the growing worldwide burden of CLD, cirrhosis was responsible for more than 35 million years of lost life and thus became the eleventh leading cause of mortality among non-communicable diseases [4]. Full-Text PDF Reply to: “Pitfalls in the non-invasive assessment of liver fibrosis with eLIFT-FMVCTE algorithm” and to “Application of the new eLIFT test for the non-invasive diagnosis of advanced liver fibrosis in people with type 2 diabetes”Journal of HepatologyVol. 68Issue 3PreviewScreening of advanced liver fibrosis: one step at a time Full-Text PDF

Non-Invasive Assessment of Liver Fibrosis Progression and Prognosis in Primary Biliary Cholangitis

Insight into the natural history of primary biliary cirrhosis: A systemic review of data from placebo-controlled clinical trials.

Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients

Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease

Diagnostic value of magnetic resonance parametric mapping for non-invasive assessment of liver fibrosis in patients with primary sclerosing cholangitis

Diagnostic Accuracy of Transient Elastography for Staging Liver Fibrosis in Autoimmune Liver Diseases: A Systematic Review and Meta-Analysis

Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B.

Noninvasive Methods for Detecting Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B: A Single-Center Retrospective Study

[Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B]

Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients

Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: an Update on MR Imaging Findings with Recent Developments

A Novel Non-Invasive Index for the Prediction of Liver Fibrosis in Chronic Hepatitis B Patients with Concurrent Nonalcoholic Fatty Liver Disease

FibroScan Predicts Liver Fibrosis Progression in Chronic HBV Infection Patients with No Clear Indication for Antiviral Therapy: A Retrospective Cohort Study

Accuracy of transient elastography in assessing fibrosis at diagnosis in individuals with autoimmune liver disease.

Plateletcrit As a Potential Index for Predicting Liver Fibrosis in Chronic Hepatitis B

A new method to estimate the histological stage of primary biliary cholangitis

Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers

Clinically significant portal hypertension in patients with primary biliary cholangitis: Clinicopathological features and prognostic value

Pitfalls in the Non-Invasive Assessment of Liver Fibrosis with Elift-Fmvcte Algorithm

Current Landscape and Evolving Therapies for Primary Biliary Cholangitis

A Novel Non-Invasive Model for the Prediction of Advanced Liver Fibrosis in Chronic Hepatitis B Patients with NAFLD.